Sincere Co (TSE:7782) PE Ratio without NRI: 17.06 (As of Jul. 08, 2026) — 39% Below Median


TSE:7782 Sincere Co Ltd TSE:7782
82 GF Score
Price 円455.00
GF Value 円669.72
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Sincere Co PE Ratio without NRI?

Sincere Co TSE:7782 -1.30% 82 PE Ratio without NRI is 17.06 as of Jul. 08, 2026, which is 39% below its 10-year median of 27.74. GuruFocus rates TSE:7782 with a GF Score™ of 82/100 and a GF Value™ of 円669.72 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 447 Medical Devices & Instruments companies, Sincere Co ranks better than 68.01% on this metric.

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. As of today (2026-07-08), Sincere Co's share price is 円455.00. Sincere Co's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was 円26.67. Therefore, Sincere Co's PE Ratio without NRI for today is 17.06.

During the past 12 years, Sincere Co's highest PE Ratio without NRI was 2041.67. The lowest was 10.62. And the median was 27.74.

Sincere Co's EPS without NRI for the three months ended in Dec. 2025 was 円0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was 円26.67.

As of today (2026-07-08), Sincere Co's share price is 円455.00. Sincere Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was 円23.00. Therefore, Sincere Co's PE Ratio (TTM) for today is 19.78.

Good Sign:

Sincere Co Ltd stock PE Ratio (=11.22) is close to 10-year low of 10.61.

During the past years, Sincere Co's highest PE Ratio (TTM) was 270.37. The lowest was 10.61. And the median was 25.77.

Sincere Co's EPS (Diluted) for the three months ended in Dec. 2025 was 円0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was 円23.00.

Sincere Co's EPS (Basic) for the three months ended in Dec. 2025 was 円0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was 円23.00.


Sincere Co  (TSE:7782) PE Ratio without NRI Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio without NRI measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.


Sincere Co PE Ratio without NRI Related Terms


Sincere Co PE Ratio without NRI Historical Data

* Premium members only.

The historical data trend for Sincere Co's PE Ratio without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sincere Co PE Ratio without NRI Chart

Sincere Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PE Ratio without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 51.33 25.77 13.86 10.32 10.41

Sincere Co Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
PE Ratio without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.32 22.53 20.18 10.41 At Loss

TSE:7782 vs ISRG, BDX, MDLN: PE Ratio without NRI Comparison

For the Medical Instruments & Supplies subindustry, Sincere Co's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sincere Co PE Ratio without NRI vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sincere Co's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Sincere Co's PE Ratio without NRI falls into.


TSE:7782
82GF Score
Sincere Co Ltd TSE:7782
PE Ratio without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sincere Co PE Ratio without NRI Calculation

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. Regular PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than regular PE Ratio.

Sincere Co's PE Ratio without NRI for today is calculated as

PE Ratio without NRI=Share Price/ EPS without NRI
=455.00/26.671
=17.06

Sincere Co's Share Price of today is 円455.00.
Sincere Co's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円26.67.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months.

For Forward PE Ratio, the earnings are the expected earnings for the next twelve months.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio without NRI →
What does a PE Ratio without NRI of 17.06 mean?
Sincere Co (TSE:7782) has a PE Ratio without NRI of 17.06 as of Jul. 08, 2026. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Sincere Co and its competitors. This is 39% below median its historical median of 27.74. Over the past decade, Sincere Co's PE Ratio without NRI has ranged from 10.62 to 2,041.67. According to the industry distribution chart, Sincere Co ranks #143 out of 447 companies in the Medical Devices & Instruments industry, placing it in the top 32%.
Is Sincere Co's PE Ratio without NRI too high?
Sincere Co's current PE Ratio without NRI of 17.06 is 39% below median its 10-year median of 27.74. Over the past 10 years, this metric has ranged from a low of 10.62 to a high of 2,041.67. The Medical Devices & Instruments industry median PE Ratio without NRI is 23.61. Sincere Co's value of 17.06 is 27.7% below this industry median. Based on the distribution chart, Sincere Co ranks #143 out of 447 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Sincere Co has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sincere Co's PE Ratio without NRI compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Sincere Co ranks #143 out of 447 companies for PE Ratio without NRI. This puts Sincere Co in the upper half of its industry. The industry median PE Ratio without NRI is 23.61. Sincere Co's value of 17.06 is 27.7% below this benchmark. Historically, Sincere Co's own PE Ratio without NRI has ranged from 10.62 to 2,041.67 over the past decade. While the company's 10-year median is 27.74 vs. the industry median of 23.61, Sincere Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio without NRI for a Medical Devices & Instruments company?
The median PE Ratio without NRI among Medical Devices & Instruments companies is 23.61, based on 447 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio without NRI significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sincere Co's current PE Ratio without NRI of 17.06 is 27.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio without NRI mean?
A high PE Ratio without NRI can signal that a stock is expensive relative to its fundamentals. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Sincere Co and its competitors. For the Medical Devices & Instruments industry, the median PE Ratio without NRI is 23.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sincere Co's current PE Ratio without NRI is 17.06, which is 39% below median its own 10-year median of 27.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sincere Co stock overvalued right now?
Based on GuruFocus' analysis, Sincere Co (TSE:7782) is currently considered Significantly Undervalued. The stock's GF Value™ is 円669.72, compared to a current price of 円455.00 — trading 32.1% below its estimated fair value. The current PE Ratio without NRI is 17.06, which is 39% below median its 10-year median of 27.74 and 27.7% below the Medical Devices & Instruments industry median of 23.61. Sincere Co's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio without NRI calculated?
PE Ratio without NRI is calculated from a company's financial statements. For Sincere Co (TSE:7782), the current PE Ratio without NRI is 17.06 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sincere Co (TSE:7782) Overvalued in 2026?

Based on GuruFocus' analysis, Sincere Co stock appears to be undervalued. The current stock price of 円455.00 is trading 32.1% below its estimated GF Value™ of 円669.72. GuruFocus considers Sincere Co to be Significantly Undervalued.

Key valuation signals for TSE:7782:

  • PE Ratio without NRI: 17.06 (39% below median its 10-year median of 27.74)
  • GF Value™: 円669.72 vs. price of 円455.00 (32.1% below fair value)
  • GF Score™: 82/100 with 2 warning signs
  • Industry Position: 27.7% below the Medical Devices & Instruments median (#143 of 447)

No single metric tells the full story. See the TSE:7782 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sincere Co Business Description

Address 1-28-34 Hongo, Bunkyo-ku, 6th Floor, Hongo MK Building, Tokyo, JPN, 113-0033
Sincere Co Ltd is a Japanese firm engaged in the manufacturing and sale of contact lens.As a company that manufactures and sells contact lenses, which are high-regulated medical devices, it place the highest priority on product safety and quality control, while working closely with company's customers to develop a variety-of-products and sell them at affordable prices to please as many customers as possible. The company opperates domestically as well as internationally.
82GF Score

Get the complete analysis for TSE:7782

PE Ratio without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円455.00
Price
円669.72
GF Value